North Carolina A&T State University
NSF Engineering Research Center + Bioengineering Joint Seminar Series
Oncolytic Viruses: A Novel Platform for Research Collaborations
John H. Stewart, IV
Wake Forest University School of Medicine
11 AM – 11:50 AM – Friday, April 4, 2014
McNair Hall Auditorium – College of Engineering
Dr. Stewart will discuss the research focus of his laboratory and team on the induction of cell death in gastrointestinal malignancies using oncolytic viruses and the role of the topic in providing an innovative platform for research collaborations.
About the Speaker:
Dr. John H. Stewart, IV, MD, FACS, is Associate Professor in the Department of General Surgery at the Wake Forest University School of Medicine and is one of eight members of the Wake Forest Baptist Health Surgical Oncology Service. In addition, he holds multiple administrative appointments there: Vice Chair of the Department, Associate Director of the Residency Program, Associate Dean for Clinical Research and Innovation, and Associate Director for Health Equity.
Dr. Stewart earned his MD from Howard University following a BS in Zoology earned from Louisiana Tech University. He completed fellowships in surgical oncology and tumor immunotherapy at the National Cancer Institute under the direction of Dr. Steven Rosenberg. In addition, he was a Harold Amos Fellow of the Robert Wood Johnson Foundation. He completed his residency in general surgery at the Vanderbilt University Medical Center in 2004.
Dr. Stewart’s clinical interests are in general surgical oncology with a focus on melanoma as well as breast, gastrointestinal, and peritoneal surface malignancies. At present, his research on oncolytic viruses is funded by the National Cancer Institute. He has published over 75 peer-reviewed manuscripts in journals including Cancer, The Journal of Thoracic and Cardiovascular Surgery, The Journal of Immunotherapy, Annals of Surgical Oncology, The Journal of Surgical Research, and The American Journal of Surgery and Transplantation. Dr. Stewart is the recipient of the 2013 National Cancer Institute Cancer Clinical Investigator Team Leadership Award.